Tradeweb Markets Inc. Free cash flow decreased by 72.0% to $94.23M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 60.9%, from $58.56M to $94.23M. Over 4 years (FY 2021 to FY 2025), Free cash flow shows an upward trend with a 19.0% CAGR. This decline may warrant attention — for this metric, higher values are generally preferred.
An increase suggests improved operational efficiency or reduced capital intensity, providing more flexibility for capital allocation. A decrease may indicate higher investment in R&D or infrastructure, or potential challenges in converting earnings into cash.
Free cash flow represents the cash generated by a company after accounting for cash outflows to support operations and m...
Large-cap medical device and pharmaceutical peers typically maintain strong, positive free cash flow, though levels vary based on the intensity of R&D spending and the lifecycle stage of major product lines.
free_cash_flow| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $144.25M | $181.19M | $184.49M | $36.18M | $172.31M | $198.37M | $202.75M | $63.96M | $208.81M | $211.09M | $243.70M | $31.33M | $280.84M | $287.82M | $256.79M | $58.56M | $403.72M | $328.27M | $336.54M | $94.23M |
| QoQ Change | — | +25.6% | +1.8% | -80.4% | +376.2% | +15.1% | +2.2% | -68.5% | +226.5% | +1.1% | +15.4% | -87.1% | +796.5% | +2.5% | -10.8% | -77.2% | +589.4% | -18.7% | +2.5% | -72.0% |
| YoY Change | — | — | — | — | +19.5% | +9.5% | +9.9% | +76.8% | +21.2% | +6.4% | +20.2% | -51.0% | +34.5% | +36.4% | +5.4% | +86.9% | +43.8% | +14.1% | +31.1% | +60.9% |